XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor and Non-Guarantor Financial Statements (Tables)
9 Months Ended
Sep. 30, 2014
Guarantor and Non-Guarantor Financial Statement [Abstract]  
Schedule of Condensed Financial Statements
CONDENSED CONSOLIDATING BALANCE SHEET
September 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$

 
$
208.6

 
$
3.7

 
$

 
$
212.3

Short-term investments
 

 
100.1

 

 

 
100.1

Receivables:
 
 
 
 
 
 
 
 
 
 
Trade, less allowance for doubtful receivables
 

 
128.0

 
4.4

 

 
132.4

Intercompany receivables
 

 
34.0

 
1.0

 
(35.0
)
 

Other
 

 
5.1

 
5.3

 

 
10.4

Inventories
 

 
205.5

 
6.6

 
(0.8
)
 
211.3

Prepaid expenses and other current assets
 
100.1

 
55.9

 
0.4

 

 
156.4

Total current assets
 
100.1

 
737.2

 
21.4

 
(35.8
)
 
822.9

Investments in and advances to subsidiaries
 
1,531.5

 
29.6

 

 
(1,561.1
)
 

Property, plant, and equipment — net
 

 
426.9

 
16.0

 

 
442.9

Long-term intercompany receivables
 

 

 
16.5

 
(16.5
)
 

Net assets of VEBAs
 

 
430.3

 

 

 
430.3

Deferred tax assets — net
 

 
17.8

 

 
8.9

 
26.7

Intangible assets — net
 

 
32.5

 

 

 
32.5

Goodwill
 

 
37.2

 

 

 
37.2

Other assets
 
4.6

 
19.1

 
0.1

 

 
23.8

Total
 
$
1,636.2

 
$
1,730.6

 
$
54.0

 
$
(1,604.5
)
 
$
1,816.3

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
0.7

 
$
80.8

 
$
7.8

 
$

 
$
89.3

Intercompany payable
 
30.2

 
11.5

 
3.1

 
(44.8
)
 

Accrued salaries, wages, and related expenses
 

 
33.7

 
3.5

 

 
37.2

Other accrued liabilities
 
109.4

 
22.1

 
0.2

 

 
131.7

Current portion of long-term debt
 
170.2

 

 

 

 
170.2

Short-term capital lease
 

 
0.1

 

 

 
0.1

Total current liabilities
 
310.5

 
148.2

 
14.6

 
(44.8
)
 
428.5

Deferred tax liability
 

 

 
1.2

 

 
1.2

Long-term intercompany payable
 

 
16.5

 

 
(16.5
)
 

Long-term liabilities
 

 
50.7

 
10.2

 

 
60.9

Long-term debt
 
225.0

 

 

 

 
225.0

Total liabilities
 
535.5

 
215.4

 
26.0

 
(61.3
)
 
715.6

 
 
 
 
 
 
 
 
 
 
 
Total stockholders’ equity
 
1,100.7

 
1,515.2

 
28.0

 
(1,543.2
)
 
1,100.7

Total
 
$
1,636.2

 
$
1,730.6

 
$
54.0

 
$
(1,604.5
)
 
$
1,816.3


CONDENSED CONSOLIDATING BALANCE SHEET
December 31, 2013
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
5.0

 
$
157.7

 
$
6.8

 
$

 
$
169.5

Short-term investments
 

 
129.5

 

 

 
129.5

Receivables:
 
 
 
 
 
 
 
 
 
 
Trade, less allowance for doubtful receivables
 

 
117.7

 
2.1

 

 
119.8

Intercompany receivables
 

 
0.1

 
0.2

 
(0.3
)
 

Other
 

 
5.3

 
8.1

 

 
13.4

Inventories
 

 
208.6

 
6.4

 
(0.6
)
 
214.4

Prepaid expenses and other current assets
 
0.1

 
43.7

 
0.4

 

 
44.2

Total current assets
 
5.1

 
662.6

 
24.0

 
(0.9
)
 
690.8

Investments in and advances to subsidiaries
 
1,437.9

 
26.5

 

 
(1,464.4
)
 

Property, plant, and equipment — net
 

 
414.0

 
15.3

 

 
429.3

Long-term intercompany receivables
 
31.3

 
1.6

 
9.5

 
(42.4
)
 

Net assets of VEBAs
 

 
406.0

 

 

 
406.0

Deferred tax assets — net
 

 
60.2

 

 
8.9

 
69.1

Intangible assets — net
 

 
33.7

 

 

 
33.7

Goodwill
 

 
37.2

 

 

 
37.2

Other assets
 
86.2

 
18.5

 
0.1

 

 
104.8

Total
 
$
1,560.5

 
$
1,660.3

 
$
48.9

 
$
(1,498.8
)
 
$
1,770.9

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
1.1

 
$
56.3

 
$
5.5

 
$

 
$
62.9

Intercompany payable
 

 
13.9

 
0.1

 
(14.0
)
 

Accrued salaries, wages, and related expenses
 

 
39.3

 
3.4

 

 
42.7

Other accrued liabilities
 
3.5

 
39.9

 
1.4

 

 
44.8

Short-term capital lease
 

 
0.2

 

 

 
0.2

Total current liabilities
 
4.6

 
149.6

 
10.4

 
(14.0
)
 
150.6

Deferred tax liability
 

 

 
1.2

 

 
1.2

Long-term intercompany payable
 

 
40.7

 
1.7

 
(42.4
)
 

Long-term liabilities
 
83.2

 
52.0

 
11.2

 

 
146.4

Long-term debt
 
388.5

 

 

 

 
388.5

Total liabilities
 
476.3

 
242.3

 
24.5

 
(56.4
)
 
686.7

 
 
 
 
 
 
 
 
 
 
 
Total stockholders’ equity
 
1,084.2

 
1,418.0

 
24.4

 
(1,442.4
)
 
1,084.2

Total
 
$
1,560.5

 
$
1,660.3

 
$
48.9

 
$
(1,498.8
)
 
$
1,770.9


CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME
Quarter Ended September 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
330.3

 
$
33.6

 
$
(25.0
)
 
$
338.9

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
274.7

 
29.8

 
(24.1
)
 
280.4

Unrealized gains on derivative instruments
 

 
3.6

 

 

 
3.6

Depreciation and amortization
 

 
7.7

 
0.3

 

 
8.0

Selling, administrative, research and development, and general
 
 
 
 
 
 
 
 
 
 
Selling, administrative, research and development, and general
 
0.9

 
17.2

 
1.7

 
(0.8
)
 
19.0

Net periodic pension benefit income relating to VEBAs
 

 
(6.0
)
 

 

 
(6.0
)
Total selling, administrative, research and development, and general
 
0.9

 
11.2

 
1.7

 
(0.8
)
 
13.0

Other operating charges, net
 

 
1.3

 

 

 
1.3

Total costs and expenses
 
0.9

 
298.5

 
31.8

 
(24.9
)
 
306.3

Operating (loss) income
 
(0.9
)
 
31.8

 
1.8

 
(0.1
)
 
32.6

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(9.4
)
 
(0.5
)
 

 
0.2

 
(9.7
)
Other income (expense), net
 
2.2

 
0.3

 
(0.1
)
 
(0.2
)
 
2.2

(Loss) income before income taxes
 
(8.1
)
 
31.6

 
1.7

 
(0.1
)
 
25.1

Income tax (provision) benefit
 

 
(11.9
)
 
(0.1
)
 
2.8

 
(9.2
)
Earnings in equity of subsidiaries
 
24.0

 
1.6

 

 
(25.6
)
 

Net income
 
$
15.9

 
$
21.3

 
$
1.6

 
$
(22.9
)
 
$
15.9

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
17.2

 
$
22.5

 
$
1.7

 
$
(24.2
)
 
$
17.2












CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME
Nine Months Ended September 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
993.1

 
$
100.7

 
$
(75.7
)
 
$
1,018.1

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
824.4

 
87.9

 
(73.5
)
 
838.8

Depreciation and amortization
 

 
22.3

 
0.8

 

 
23.1

Selling, administrative, research and development, and general
 
 
 
 
 
 
 
 
 
 
Selling, administrative, research and development, and general
 
3.1

 
52.3

 
7.9

 
(2.0
)
 
61.3

Net periodic pension benefit income relating to VEBAs
 

 
(17.7
)
 

 

 
(17.7
)
Total selling, administrative, research and development, and general
 
3.1

 
34.6

 
7.9

 
(2.0
)
 
43.6

Other operating charges, net
 

 
1.5

 

 

 
1.5

Total costs and expenses
 
3.1

 
882.8

 
96.6

 
(75.5
)
 
907.0

Operating (loss) income
 
(3.1
)
 
110.3

 
4.1

 
(0.2
)
 
111.1

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(28.0
)
 
(0.1
)
 

 
0.4

 
(27.7
)
Other income, net
 
3.6

 
2.3

 
0.4

 
(0.4
)
 
5.9

(Loss) income before income taxes
 
(27.5
)
 
112.5

 
4.5

 
(0.2
)
 
89.3

Income tax (provision) benefit
 

 
(42.3
)
 
(0.9
)
 
10.1

 
(33.1
)
Earnings in equity of subsidiaries
 
83.7

 
3.4

 

 
(87.1
)
 

Net income
 
$
56.2

 
$
73.6

 
$
3.6

 
$
(77.2
)
 
$
56.2

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
60.5

 
$
77.7

 
$
3.8

 
$
(81.5
)
 
$
60.5







CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Quarter Ended September 30, 2013
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
315.1

 
$
29.1

 
$
(24.3
)
 
$
319.9

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
255.8

 
26.8

 
(23.1
)
 
259.5

Unrealized losses on derivative instruments
 

 
(1.5
)
 

 

 
(1.5
)
Depreciation and amortization
 

 
6.6

 
0.3

 

 
6.9

Selling, administrative, research and development, and general
 
 
 
 
 
 
 
 
 
 
Selling, administrative, research and development, and general
 
1.3

 
16.9

 
2.0

 
(1.2
)
 
19.0

Net periodic pension benefit income relating to VEBAs
 

 
(5.6
)
 

 

 
(5.6
)
Total selling, administrative, research and development, and general
 
1.3

 
11.3

 
2.0

 
(1.2
)
 
13.4

Total costs and expenses
 
1.3

 
272.2

 
29.1

 
(24.3
)
 
278.3

Operating (loss) income
 
(1.3
)
 
42.9

 

 

 
41.6

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest (expense) income
 
(9.2
)
 
0.3

 

 
0.1

 
(8.8
)
Other income, net
 
2.2

 
0.5

 
0.4

 
(0.2
)
 
2.9

(Loss) income before income taxes
 
(8.3
)
 
43.7

 
0.4

 
(0.1
)
 
35.7

Income tax (provision) benefit
 

 
(18.0
)
 
4.4

 
3.3

 
(10.3
)
Earnings in equity of subsidiaries
 
33.7

 
4.8

 

 
(38.5
)
 

Net income
 
$
25.4

 
$
30.5

 
$
4.8

 
$
(35.3
)
 
$
25.4

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
26.0

 
$
31.4

 
$
4.5

 
$
(35.9
)
 
$
26.0









CONDENSED CONSOLIDATING STATEMENT OF COMPREHESIVE INCOME
Nine Months Ended September 30, 2013
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
971.6

 
$
89.1

 
$
(74.5
)
 
$
986.2

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
774.4

 
80.1

 
(69.9
)
 
784.6

Unrealized losses on derivative instruments
 

 
3.4

 

 

 
3.4

Depreciation and amortization
 

 
20.1

 
0.8

 

 
20.9

Selling, administrative, research and development, and general
 
 
 
 
 
 
 
 
 
 
Selling, administrative, research and development, and general
 
2.8

 
57.5

 
6.5

 
(4.3
)
 
62.5

Net periodic pension benefit income relating to VEBAs
 

 
(16.9
)
 

 

 
(16.9
)
Total selling, administrative, research and development, and general
 
2.8

 
40.6

 
6.5

 
(4.3
)
 
45.6

Total costs and expenses
 
2.8

 
838.5

 
87.4

 
(74.2
)
 
854.5

Operating (loss) income
 
(2.8
)
 
133.1

 
1.7

 
(0.3
)
 
131.7

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(27.3
)
 

 

 
0.2

 
(27.1
)
Other income, net
 
1.7

 
1.4

 
0.3

 
(0.3
)
 
3.1

(Loss) income before income taxes
 
(28.4
)
 
134.5

 
2.0

 
(0.4
)
 
107.7

Income tax (provision) benefit
 

 
(52.1
)
 
10.9

 
11.0

 
(30.2
)
Earnings in equity of subsidiaries
 
105.9

 
12.5

 

 
(118.4
)
 

Net income
 
$
77.5

 
$
94.9

 
$
12.9

 
$
(107.8
)
 
$
77.5

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
80.6

 
$
97.5

 
$
13.4

 
$
(110.9
)
 
$
80.6



















CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Nine Months Ended September 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
 
$
13.9

 
$
82.7

 
$
7.1

 
$

 
$
103.7

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(38.1
)
 
(1.5
)
 

 
(39.6
)
Purchase of available for sale securities
 

 
(53.4
)
 

 

 
(53.4
)
Proceeds from disposition of available for sale securities
 

 
82.2

 

 

 
82.2

Change in restricted cash
 

 
(0.7
)
 

 

 
(0.7
)
Net cash used in investing activities
 

 
(10.0
)
 
(1.5
)
 

 
(11.5
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest
 

 
0.8

 

 

 
0.8

Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares
 
(2.4
)
 

 

 

 
(2.4
)
Repurchase of common stock
 
(28.7
)
 

 

 

 
(28.7
)
Cash dividend paid to stockholders
 
(19.1
)
 

 

 

 
(19.1
)
Intercompany loan
 
31.3

 
(22.6
)
 
(8.7
)
 

 

Net cash used in financing activities
 
(18.9
)
 
(21.8
)
 
(8.7
)
 

 
(49.4
)
Net (decrease) increase in cash and cash equivalents during the period
 
(5.0
)
 
50.9

 
(3.1
)
 

 
42.8

Cash and cash equivalents at beginning of period
 
5.0

 
157.7

 
6.8

 

 
169.5

Cash and cash equivalents at end of period
 
$

 
$
208.6

 
$
3.7

 
$

 
$
212.3

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Nine Months Ended September 30, 2013
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
 
$
(15.6
)
 
$
102.8

 
$
3.4

 
$

 
$
90.6

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(44.8
)
 
(2.2
)
 

 
(47.0
)
Purchase of available for sale securities
 

 
(201.8
)
 

 

 
(201.8
)
Proceeds from disposition of available for sale securities
 

 
170.7

 

 

 
170.7

Change in restricted cash
 

 
0.7

 

 

 
0.7

Net cash used in investing activities
 

 
(75.2
)
 
(2.2
)
 

 
(77.4
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest
 

 
1.0

 

 

 
1.0

Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares
 
(2.4
)
 

 

 

 
(2.4
)
Repurchase of common stock
 
(43.9
)
 

 

 

 
(43.9
)
Cash dividend paid to stockholders
 
(17.3
)
 

 

 

 
(17.3
)
Cash dividend returned to the Company
 
0.6

 

 

 

 
0.6

Intercompany loan
 
78.6

 
(77.5
)
 
(1.1
)
 

 

Net cash provided by (used in) financing activities
 
15.6

 
(76.5
)
 
(1.1
)
 

 
(62.0
)
Net (decrease) increase in cash and cash equivalents during the period
 

 
(48.9
)
 
0.1

 

 
(48.8
)
Cash and cash equivalents at beginning of period
 
5.0

 
266.0

 
2.4

 

 
273.4

Cash and cash equivalents at end of period
 
$
5.0

 
$
217.1

 
$
2.5

 
$

 
$
224.6